Risk stratification of the apparently healthy population with ARCHITECT STAT High Sensitive Troponin-I

Sponsored by: Abbott

Speaker

Event Date & Time

DATE: December 18, 2018

TIME: 7:00am CST, 8:00am EST

Abstract

In this webinar you will hear about a recently CE marked application for ARCHITECT STAT High Sensitive Troponin I, that aids in providing greater accuracy for estimation of risk for future cardiac events in apparently healthy people, when used in conjunction with clinical and diagnostics findings. Risk is classified as low, moderate or elevated and use of ARCHITECT STAT High Sensitive Troponin I, is supported by a large body of evidence. This simple blood test can aid in earlier intervention for high risk patients and may avoid unnecessary tests and treatments in low risk patients.

ARCHITECT STAT High Sensitive Troponin I, is well known to many through its use in Emergency Departments where it has been trusted for many years to rule in or rule out Myocardial Infarction. This latest application sets the stage to support tackling the cardiovascular disease burden through prevention.

Learning objectives:

Understand the limitations of current risk assessment tools
Understand how addition of ARCHITECT STAT High Sensitive Troponin I into assessment algorithms can assist in predicting risk
Understand how addition of ARCHITECT STAT High Sensitive Troponin I into assessment algorithms can assist in earlier patient management for those at high risk
Understand how addition of ARCHITECT STAT High Sensitive Troponin I into assessment algorithms can assist in avoiding unnecessary tests and treatments in low risk patients
Understand how addition of ARCHITECT STAT High Sensitive Troponin I into assessment algorithms can assist in reducing the growing cost burden of cardiovascular disease
Understand the body of evidence